Read + Share
Ni L, Li Y, Wu K, Deng F, et al. Antitumor efficacy of CRISPR/Cas9-engineered ICP6 mutant herpes simplex viruses
in a mouse xenograft model for lung adenocarcinoma. J Med Virol 2022 Aug 14. doi: 10.1002/jmv.28069.
PMID: 35965331
|
 |
|
Ni L, Li Y, Wu K, Deng F, et al. Antitumor efficacy of CRISPR/Cas9-engineered ICP6 mutant herpes simplex viruses
in a mouse xenograft model for lung adenocarcinoma. J Med Virol 2022 Aug 14. doi: 10.1002/jmv.28069.
PMID: 35965331
|
|
|
|